ProMIS Neurosciences (PMN) News Today → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free PMN Stock Alerts Add Compare Share Share HeadlinesStock AnalysisEarningsHeadlinesInsider TradesStock AnalysisEarningsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePMN Stock Earnings: ProMIS Neurosciences Beats EPS for Q4 2023msn.com - April 1 at 11:08 PMProMIS Neurosciences to Present at the 2024 BIO CEO & Investor Conferencefinance.yahoo.com - February 22 at 8:26 AMNerve stimulation plus physical rehabilitation may boost recovery of arm and hand functionmsn.com - February 1 at 3:10 PMProMIS Neurosciences Issues Letter to Shareholdersmarkets.businessinsider.com - January 8 at 8:10 AMProMIS Neurosciences Inc.: ProMIS Neurosciences Announces Publication on Novel Target for ALSfinanznachrichten.de - December 20 at 9:09 AMProMIS Neurosciences Doses First Subjects in Phase 1a Clinical Trial of PMN310 to Treat Alzheimer’s Diseasemarkets.businessinsider.com - November 20 at 8:01 AMProMIS Neurosciences Announces Third Quarter 2023 Financial Results and Recent Highlightsfinance.yahoo.com - November 14 at 5:10 PMProMIS Neurosciences Closes $20.4 Million Private Placement Financingfinance.yahoo.com - September 8 at 8:49 AMProMIS Neurosciences Shares Jump on $20.4 Million Private Placementmarketwatch.com - August 22 at 6:02 PMProMIS Neurosciences Inc.: ProMIS Neurosciences Announces Second Quarter 2023 Financial Results and Recent Highlightsfinanznachrichten.de - August 15 at 9:56 AMProMIS Neurosciences Announces Second Quarter 2023 Financial Results and Recent Highlightsfinance.yahoo.com - August 14 at 6:56 PMPMN ProMIS Neurosciences, Inc.seekingalpha.com - August 1 at 6:38 AMToronto Stocks Edge Lower; ProMIS Neurosciences Soars on Positive Alzheimer's Treatment Datamarketwatch.com - July 17 at 5:33 PMAlzheimer’s Drug Data Sends ProMIS Vaulting Upmsn.com - July 17 at 5:33 PMWhy ProMIS Neurosciences Stock Surged Todaymsn.com - July 17 at 5:33 PMProMIS stock rockets 115% amid preclinical data for Alzheimer's drugmsn.com - July 17 at 5:33 PMProMIS Showcases Preclinical Data at the Alzheimer’s Association International Conference 2023 on Computationally-Derived Antibody and Vaccine from Alzheimer’s Pipelinefinance.yahoo.com - July 17 at 7:32 AMProMIS Announces Completion of Continuancefinance.yahoo.com - July 14 at 10:30 AMProMIS Neurosciences Inc.: ProMIS Neurosciences to Consolidate Trading on the Nasdaq Exchangefinanznachrichten.de - July 10 at 3:22 PMProMIS Neurosciences to Consolidate Trading on the Nasdaq Exchangefinance.yahoo.com - July 10 at 10:21 AMProMIS Neurosciences Holds Annual Meeting of Shareholders All Resolutions Approvedfinance.yahoo.com - June 30 at 8:50 AMCORRECTION: Updated URL to Access ProMIS Annual Meeting of Shareholders on June 29, 2023 at 9:30am Eastern Timefinance.yahoo.com - June 29 at 9:09 AMProMIS Neurosciences Inc.: ProMIS Neurosciences Announces First Quarter 2023 Financial Results and Recent Highlightsfinanznachrichten.de - May 16 at 8:38 AMProMIS Neurosciences Announces FDA Clearance of Investigational New Drug (IND) Application for PMN310 in Alzheimer’s Diseasefinance.yahoo.com - May 8 at 12:46 PMClosing Bell: Promis Neurosciences Inc up on Wednesday (PMN)theglobeandmail.com - April 27 at 1:44 AMClosing Bell: Promis Neurosciences Inc down on Wednesday (PMN)theglobeandmail.com - April 19 at 10:33 PMProMIS Neurosciences submits IND application for Alzheimer's treatmentproactiveinvestors.com - April 10 at 10:00 AMProMIS Neurosciences Announces Submission of Investigational New Drug (IND) Application for Lead Antibody PMN310finance.yahoo.com - April 10 at 10:00 AMLead Therapeutic Candidate, PMN310, Demonstrates Enhanced Selectivity for Toxic Oligomers Compared to Other Amyloid-Beta-Directed Antibodies in Poster Presentation at AD/PD 2023finance.yahoo.com - March 29 at 10:29 AMProMIS Neurosciences to Present New Preclinical Data for PMN310 at AD/PD 2023finance.yahoo.com - March 13 at 9:18 AMProMIS Neurosciences Announces Abstracts Accepted for Presentation at the American Academy of Neurology 2023 Annual Meetingfinance.yahoo.com - March 13 at 9:18 AMPMN.TO - | Stock Price & Latest News | Reutersreuters.com - January 22 at 3:03 PMPMN:CA ProMIS Neurosciences, Inc.seekingalpha.com - October 26 at 11:22 PMProMIS Neurosciences, Inc. (PMN)finance.yahoo.com - October 17 at 7:12 AMCan ProMIS Neurosciences (TSE:PMN) Afford To Invest In Growth?finance.yahoo.com - August 15 at 11:55 AMProMIS Neurosciences Presents at 2022 Alzheimer's Association International Conferencefinancialpost.com - August 4 at 3:05 AMProMIS Neurosciences Presents at 2022 Alzheimer’s Association International Conferencefinance.yahoo.com - August 2 at 9:49 AMProMIS Neurosciences to Present at 2022 Alzheimer’s Association International Conferencefinance.yahoo.com - July 27 at 8:08 AMProMIS Neurosciences Rings the Closing Bellnasdaq.com - July 15 at 11:34 AMProMIS at 52-Week Highca.finance.yahoo.com - July 1 at 3:17 AMProMIS Neurosciences Inc.: ProMIS Neurosciences announces reverse share split to meet NASDAQ listing criteriafinanznachrichten.de - June 27 at 8:24 AMPROMIS ANNOUNCES REVERSE SHARE SPLIT TO MEET NASDAQ LISTING CRITERIAfinance.yahoo.com - June 27 at 8:24 AMStocks in play: ProMIS Neurosciences Inc.ca.finance.yahoo.com - June 22 at 4:44 PMStocks in play: ProMIS Neurosciences Incca.finance.yahoo.com - May 13 at 5:50 PMProMIS Neurosciences Announces First Quarter 2022 Resultsfinance.yahoo.com - May 13 at 5:50 PMProMIS Holds Annual and Special Meeting of Shareholders All Resolutions Approvedfinance.yahoo.com - May 13 at 5:50 PMCORRECTION: ProMIS Neurosciences Announces First Quarter 2022 Resultsfinance.yahoo.com - May 13 at 5:50 PMProMIS Neurosciences (TSE:PMN) Is Using Debt Safelyfinance.yahoo.com - May 10 at 7:03 PMIndependent Proxy Advisory Firms, ISS and Glass Lewis, Recommend ProMIS Shareholders Vote FOR All Proposed Items at the Upcoming Annual and Special Meeting of Shareholdersfinance.yahoo.com - May 3 at 3:50 PMArgus Research Initiates Equity Report Coverage on ProMIS Neurosciences, Inc. (TSX:PMN & OTCQB: ARFXF)finance.yahoo.com - April 18 at 1:49 PM Get ProMIS Neurosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PMN and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. PMN Media Mentions By Week PMN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PMN News Sentiment▼0.000.33▲Average Medical News Sentiment PMN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PMN Articles This Week▼00▲PMN Articles Average Week Get ProMIS Neurosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PMN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Small Pharma News Today Microbix Biosystems News Today IBEX Technologies News Today Aptose Biosciences News Today Covalon Technologies News Today Theratechnologies News Today Ceapro News Today Kane Biotech News Today Reunion Neuroscience News Today Antibe Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:PMN) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProMIS Neurosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
